Emergent Biosolutions
EBS
EBS
244 hedge funds and large institutions have $2.35B invested in Emergent Biosolutions in 2019 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 89 increasing their positions, 90 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
244
Holders Change
+11
Holders Change %
+4.72%
% of All Funds
5.36%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
32
Increased
89
Reduced
90
Closed
20
Calls
$371K
Puts
$2.75M
Net Calls
-$2.38M
Net Calls Change
-$2.39M
Top Buyers
| 1 |
Millennium Management
New York
|
$19.6M |
| 2 |
SAM
Silvercrest Asset Management
New York
|
$17M |
| 3 |
Marshall Wace
London,
United Kingdom
|
$15.4M |
| 4 |
Neuberger Berman Group
New York
|
$127M |
| 5 |
TCM
Tygh Capital Management
Portland,
Oregon
|
$15.6M |
